Annogen is excited to confirm our attendance at the upcoming Advanced Therapies Congress, scheduled for March 17th – 18th, 2026, at ExCeL London!
We invite you to schedule a meeting to learn more about how Annogen can support your research and development efforts. Our team will be on hand to discuss our platform, answer your questions, and explore potential collaborations.
As a key innovator in the advanced therapy space, we look forward to engaging with senior industry executives, pioneering pharma/biotech leaders, and potential partners at Europe’s foremost commercial cell and gene therapy event. We will be featuring our proprietary promoter and expression locus discovery platform.
This Congress is recognized as the definitive commercial gathering for the ATMP sector, uniting over 3,300 global leaders to explore the latest strategies and technologies propelling the industry forward. It represents a vital opportunity to network with decision-makers across the entire value chain—including regulators, payers, and groundbreaking companies—and we anticipate contributing meaningfully to these high-impact discussions.
Annogen’s core focus is accelerating the development of genetic therapies through our sophisticated SuRE promoter discovery platform. This technology enables researchers to identify and fine-tune promoters essential for highly precise and effective gene expression, culminating in more powerful and directed therapeutic outcomes. We are confident our platform is instrumental in shaping the next evolution of gene therapies, and we are eager to demonstrate its immense potential to the industry’s leaders.
We are looking forward to engaging discussions, forging new connections, and contributing to the vibrant community. If you’re attending the conference, please reach out to schedule a meeting with our team – we’d love to connect!
See you in London!
